Navigation Links
KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
Date:10/11/2007

ended March 31, 2007, and for the first quarter of fiscal 2008; (15) actions by the Securities and Exchange Commission and the Internal Revenue Service with respect to the Company's stock option grants and accounting practices; and (16) the risks detailed from time-to-time in the Company's filings with the Securities and Exchange Commission.

This discussion is by no means exhaustive, but is designed to highlight important factors that may impact the Company's outlook. We are under no obligation to update any of the forward-looking statements after the date of this release.


'/>"/>
SOURCE KV Pharmaceutical Company
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
... that African American mothers were three times mo...thers. //They were also more than 5 times more lik...a from over 700,000 births in Missouri from 1989 t... American mothers were 3 times more likely than Ca...
...rapy device may help people regain strength and no...according to a University of California, Irvine st...rted improved ability to grasp and release objects...-Wrist Assisting Robotic Device (HOWARD). Each pat...
..." condition called nephrogenic systemic fibrosis (...kidney disease—is strongly// related to use of gad... March Clinical Journal of the American Society of...l identifies specific groups of patients in whom g...
...esothelioma — a form of cancer associated with asb...treated with a combination// of two cancer drugs, ...are but aggressive form of cancer that occurs in t...rt and abdomen, is associated with exposure to asb...
Other Medicine News:Health News:Robotic Therapy Helps Restore Hand Use After Stroke 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 3Health News:MRI Contrast Agent Linked to Complication in Renal Patients 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3
(Date:10/6/2008)...r 7 /-,Sosei Group Corporat...,Group plc ("Vectura"; LSE: VEC), announce results...safety and tolerability of NVA237 presented at the...ty (ERS) in Berlin,Germany. The new data show tha... long-acting muscarinic antagonist (LAMA), provide...
(Date:10/6/2008)...e understanding of and possible treatment...RICA, Mass., Oct. 6 /- Seahorse Biosc...r analytical instrument for the,kinetic measuremen...mic,glycolysis in cells in a 96 well microplate. F...bioenergetics have been relatively unchanged since...
(Date:10/6/2008)...he American College of Nutrition ...Newswire/ -- New research on the benefits of,probi... American College of,Nutrition (ACN) Annual Meetin...otics in Health and Disease." Scientific experts i...iscussed the potential uses for,probiotics in chil...
(Date:10/6/2008)...t. 6 /- Complete,Genomics Inc., a new...ing,company, and the Institute for Systems Biology...t populationwide human genome studies., In phase ... proprietary,DNA sequencing technology to sequence...once proof-of-concept has been demonstrated, ISB a...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 1BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 2BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 3Photo monitoring whale sharks 1728 1Photo monitoring whale sharks 1728 2Why fish oil is good for you 8785 1Why fish oil is good for you 8785 2Why fish oil is good for you 8785 3Anthracyclines improve survival in HER2 positive breast cancer patients 8782 1Anthracyclines improve survival in HER2 positive breast cancer patients 8782 2
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: